These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 24531702

  • 21. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA, Perez RO, Habr-Gama A, São Julião GP, Vailati BB, Fernandez LM, de Sousa JB, Buchpiguel CA.
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [Abstract] [Full Text] [Related]

  • 22. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH.
    Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
    [Abstract] [Full Text] [Related]

  • 23. [Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum].
    Delrio P, Lastoria S, Avallone A, Ravo V, Guida C, Cremona F, Izzo F, Palaia R, Ruffolo F, Puppio B, Guidetti GM, Cascini GL, Casaretti R, Tatangelo F, Marone P, Rossi GB, Budillon A, Petrillo A, De Rosa V, Comella G, Morrica B, Tempesta A, Botti G, Parisi V.
    Tumori; 2003 Jan; 89(4 Suppl):50-3. PubMed ID: 12903544
    [Abstract] [Full Text] [Related]

  • 24. Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil?
    Gunduz S, Coskun HS, Arslan D, Goksu SS, Tatli AM, Uysal M, Ozdogan M, Savas B.
    Indian J Cancer; 2014 Jan; 51(2):138-41. PubMed ID: 25104195
    [Abstract] [Full Text] [Related]

  • 25. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP, de Haas RJ, Murshid KJA, de Jong KP, Dierckx RAJO, Kwee TC.
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [Abstract] [Full Text] [Related]

  • 26. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C.
    Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
    [Abstract] [Full Text] [Related]

  • 27. Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus.
    Malik V, Lucey JA, Duffy GJ, Wilson L, McNamara L, Keogan M, Gillham C, Reynolds JV.
    J Nucl Med; 2010 Dec; 51(12):1863-9. PubMed ID: 21078796
    [Abstract] [Full Text] [Related]

  • 28. Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
    Groheux D, Hatt M, Hindié E, Giacchetti S, de Cremoux P, Lehmann-Che J, Martineau A, Marty M, Cuvier C, Cheze-Le Rest C, de Roquancourt A, Visvikis D, Espié M.
    Cancer; 2013 Jun 01; 119(11):1960-8. PubMed ID: 23504954
    [Abstract] [Full Text] [Related]

  • 29. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e439-45. PubMed ID: 21641122
    [Abstract] [Full Text] [Related]

  • 30. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV.
    Acta Oncol; 2012 May 15; 51(5):636-44. PubMed ID: 22208782
    [Abstract] [Full Text] [Related]

  • 31. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
    Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, Aloj L, De Martinis F, Comella P, Parisi V, Lastoria S.
    J Nucl Med; 2006 Aug 15; 47(8):1241-8. PubMed ID: 16883000
    [Abstract] [Full Text] [Related]

  • 32. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY, Wang XD, Li M, Liu XJ, Ye Z, Song B, Yuan F, Yuan Y, Xia CC, Zhang X, Li Q.
    World J Gastroenterol; 2020 May 21; 26(19):2388-2402. PubMed ID: 32476800
    [Abstract] [Full Text] [Related]

  • 33. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.
    Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, Aerts HJ, Lambin P, Lammering G.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):392-9. PubMed ID: 19646825
    [Abstract] [Full Text] [Related]

  • 34. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
    Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M.
    J Nucl Med; 2014 Jun 01; 55(6):891-7. PubMed ID: 24752672
    [Abstract] [Full Text] [Related]

  • 35. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
    Capirci C, Rubello D, Chierichetti F, Crepaldi G, Fanti S, Mandoliti G, Salviato S, Boni G, Rampin L, Polico C, Mariani G.
    AJR Am J Roentgenol; 2006 Aug 01; 187(2):W202-8. PubMed ID: 16861513
    [Abstract] [Full Text] [Related]

  • 36. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
    Sun W, Xu J, Hu W, Zhang Z, Shen W.
    Colorectal Dis; 2013 May 01; 15(5):e231-8. PubMed ID: 23384167
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
    Leibold T, Akhurst TJ, Chessin DB, Yeung HW, Macapinlac H, Shia J, Minsky BD, Saltz LB, Riedel E, Mazumdar M, Paty PB, Weiser MR, Wong WD, Larson SM, Guillem JG.
    Ann Surg Oncol; 2011 Oct 01; 18(10):2783-9. PubMed ID: 21476107
    [Abstract] [Full Text] [Related]

  • 38. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
    Capirci C, Rubello D, Chierichetti F, Crepaldi G, Carpi A, Nicolini A, Mandoliti G, Polico C.
    Biomed Pharmacother; 2004 Oct 01; 58(8):451-7. PubMed ID: 15464875
    [Abstract] [Full Text] [Related]

  • 39. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F, De Cobelli F, Canevari C, Orsenigo E, Gallivanone F, Esposito A, Castiglioni I, Ambrosi A, Albarello L, Mazza E, Gianolli L, Staudacher C, Del Maschio A.
    J Magn Reson Imaging; 2014 Nov 01; 40(5):1147-57. PubMed ID: 24214734
    [Abstract] [Full Text] [Related]

  • 40. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y.
    J Nucl Med; 2003 Feb 01; 44(2):198-206. PubMed ID: 12571209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.